Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,22305084,flow rate,"Separation was achieved on a Phenomenex Gemini C(18) column (50 mm × 2.0 mm, 5 μm) using an isocratic mobile phase system composed of methanol-ammonium formate (10 mM)-formic acid (56:44:0.2, v/v/v) (pH 3.5) at a flow rate of 0.2 mL/min.","Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22305084/),[ml] / [min],0.2,80534,DB00645,Dyclonine
,22305084,m/z,"The monitoring ions were (m/z) 247.4 → (m/z) 81.9 for tinidazole, (m/z) 290.1 → (m/z) 97.8 for dyclonine, (m/z) 505.0 → (m/z) 335.3 for chlorhexidine and (m/z) 282.1 → (m/z) 212.0 for phentolamine (internal standard).","Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22305084/),,247.4,80535,DB00645,Dyclonine
,22305084,m/z,"The monitoring ions were (m/z) 247.4 → (m/z) 81.9 for tinidazole, (m/z) 290.1 → (m/z) 97.8 for dyclonine, (m/z) 505.0 → (m/z) 335.3 for chlorhexidine and (m/z) 282.1 → (m/z) 212.0 for phentolamine (internal standard).","Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22305084/),,290.1,80536,DB00645,Dyclonine
,22305084,m/z,"The monitoring ions were (m/z) 247.4 → (m/z) 81.9 for tinidazole, (m/z) 290.1 → (m/z) 97.8 for dyclonine, (m/z) 505.0 → (m/z) 335.3 for chlorhexidine and (m/z) 282.1 → (m/z) 212.0 for phentolamine (internal standard).","Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22305084/),,505.0,80537,DB00645,Dyclonine
,22305084,m/z,"The monitoring ions were (m/z) 247.4 → (m/z) 81.9 for tinidazole, (m/z) 290.1 → (m/z) 97.8 for dyclonine, (m/z) 505.0 → (m/z) 335.3 for chlorhexidine and (m/z) 282.1 → (m/z) 212.0 for phentolamine (internal standard).","Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22305084/),,335.3,80538,DB00645,Dyclonine
,22305084,m/z,"The monitoring ions were (m/z) 247.4 → (m/z) 81.9 for tinidazole, (m/z) 290.1 → (m/z) 97.8 for dyclonine, (m/z) 505.0 → (m/z) 335.3 for chlorhexidine and (m/z) 282.1 → (m/z) 212.0 for phentolamine (internal standard).","Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22305084/),,282.1,80539,DB00645,Dyclonine
,22305084,m/z,"The monitoring ions were (m/z) 247.4 → (m/z) 81.9 for tinidazole, (m/z) 290.1 → (m/z) 97.8 for dyclonine, (m/z) 505.0 → (m/z) 335.3 for chlorhexidine and (m/z) 282.1 → (m/z) 212.0 for phentolamine (internal standard).","Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22305084/),,212.0,80540,DB00645,Dyclonine
